749 results on '"Kurtin, Paul J"'
Search Results
2. Aberrant expression of lymphoid enhancer–binding factor 1 in Hodgkin lymphoma
3. Carboxypeptidase A1 and regenerating islet-derived 1α as new markers for pancreatic acinar cell carcinoma
4. Amyloid Typing by Mass Spectrometry in Clinical Practice: a Comprehensive Review of 16,175 Samples
5. Amyloidosis in surgically resected atrial appendages: a study of 345 consecutive cases with clinical implications
6. First Report of Bilateral External Auditory Canal Cochlin Aggregates (“Cochlinomas”) with Multifocal Amyloid-Like Deposits, Associated with Sensorineural Hearing Loss and a Novel Genetic Variant in COCH Encoding Cochlin
7. Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?
8. The sensitivity and specificity of the routine kidney biopsy immunofluorescence panel are inferior to diagnosing renal immunoglobulin-derived amyloidosis by mass spectrometry
9. Incidence of AL Amyloidosis in Olmsted County, Minnesota, 1990 through 2015
10. Unusual duplication mutation in a surface loop of human transthyretin leads to an aggressive drug-resistant amyloid disease
11. Apolipoprotein CII Amyloidosis Associated With p.Lys41Thr Mutation
12. Congophilic Fibrillary Glomerulonephritis: A Case Series
13. Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma
14. DNAJB9 Is a Specific Immunohistochemical Marker for Fibrillary Glomerulonephritis
15. Acquired transthyretin amyloidosis after domino liver transplant: Phenotypic correlation, implication of liver retransplantation
16. Clinical, biopsy, and mass spectrometry findings of renal gelsolin amyloidosis
17. Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light-chain amyloidosis by mass spectrometry
18. Lymph Node
19. Clinical, biopsy, and mass spectrometry characteristics of renal apolipoprotein A-IV amyloidosis
20. Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma
21. Leukocyte chemotactic factor 2 amyloidosis (ALECT2) is a common form of renal amyloidosis among Egyptians
22. High level MYC amplification in B-cell lymphomas: is it a marker of aggressive disease?
23. Follicular Dendritic Cell Sarcoma With Indolent T-Lymphoblastic Proliferation is Associated With Paraneoplastic Autoimmune Multiorgan Syndrome
24. Renal extramedullary hematopoiesis: interstitial and glomerular pathology
25. Hematologic Characteristics of Proliferative Glomerulonephritides With Nonorganized Monoclonal Immunoglobulin Deposits
26. Lymph Node
27. Contributors
28. Small B-Cell Lymphomas
29. Renal Amyloidosis Associated With a Novel Sequence Variant of Gelsolin
30. Lymph Node and Spleen
31. Bone Marrow
32. Spheroid‐type of AL amyloid deposition associated with colonic adenocarcinoma: A case report with literature review
33. Application of Immunohistochemistry in the Diagnosis of Lymphoid Lesions
34. Long‐term follow‐up of chemoimmunotherapy with rituximab, oxaliplatin, cytosine arabinoside, dexamethasone (ROAD) in patients with relapsed CD20+ B–cell non‐Hodgkin lymphoma: Results of a study of the Mayo Clinic Cancer Center Research Consortium (MCCRC) MC0485 now known as academic and community cancer research united (ACCRU)
35. Characterization of C3 in C3 glomerulopathy
36. Endobronchial Ultrasound and Lymphoproliferative Disorders: A Retrospective Study
37. Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders
38. Proteomic Identification and Clinicopathologic Characterization of Splenic Amyloidosis
39. Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas
40. Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma
41. Bone marrow histopathology in POEMS syndrome: a distinctive combination of plasma cell, lymphoid, and myeloid findings in 87 patients
42. Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 study
43. Hereditary Lysozyme Amyloidosis Variant p.Leu102Ser Associates with Unique Phenotype
44. Novel Type of Renal Amyloidosis Derived from Apolipoprotein-CII
45. Correlation of histomorphological pattern of cardiac amyloid deposition with amyloid type: a histological and proteomic analysis of 108 cases
46. Is It Time for a New Gold Standard? FISH vs Cytogenetics in AML Diagnosis
47. Bone marrow amyloid: a comprehensive analysis of 1,469 samples, including amyloid type, clinical features, and morphologic distribution
48. Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma
49. LMO2 Is a Specific Marker of T-Lymphoblastic Leukemia/Lymphoma
50. Conventional Karyotyping and Fluorescence In Situ Hybridization: An Effective Utilization Strategy in Diagnostic Adult Acute Myeloid Leukemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.